Dapagliflozin as Prophylaxis for Glucocorticoid-Induced Hyperglycemia

Clinical trial NCT06748105 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06748105
Sponsor: Lauro Fabián Amador Medina
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Dapagliflozin (Forxiga)Hyperglycaemia Glucocorticoid

Start date: 2024-12-01
Primary completion: 2025-12-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.